These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33207935)

  • 21. Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.
    Simioni N; Labreuche J; Behal H; Cottencin O; Rolland B
    J Clin Psychopharmacol; 2017 Dec; 37(6):722-728. PubMed ID: 28984747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations.
    Rasmussen DD; Kincaid CL; Froehlich JC
    Alcohol Alcohol; 2017 Jan; 52(1):5-11. PubMed ID: 27797712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
    Falk DE; Ryan ML; Fertig JB; Devine EG; Cruz R; Brown ES; Burns H; Salloum IM; Newport DJ; Mendelson J; Galloway G; Kampman K; Brooks C; Green AI; Brunette MF; Rosenthal RN; Dunn KE; Strain EC; Ray L; Shoptaw S; Ait-Daoud Tiouririne N; Gunderson EW; Ransom J; Scott C; Leggio L; Caras S; Mason BJ; Litten RZ;
    Alcohol Clin Exp Res; 2019 Jan; 43(1):158-169. PubMed ID: 30403402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
    Ray LA; Chin PF; Heydari A; Miotto K
    Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, 12 month follow-up, placebo-controlled trial of mifepristone on cognition in alcoholics: the MIFCOG trial protocol.
    Donoghue K; Rose A; Coulton S; Milward J; Reed K; Drummond C; Little H
    BMC Psychiatry; 2016 Feb; 16():40. PubMed ID: 26912003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
    Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
    Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender Differences in Affects and Craving in Alcohol-Dependence: A Study During Alcohol Detoxification.
    Petit G; Luminet O; Cordovil de Sousa Uva M; Monhonval P; Leclercq S; Spilliaert Q; Zammit F; Maurage P; de Timary P
    Alcohol Clin Exp Res; 2017 Feb; 41(2):421-431. PubMed ID: 28060415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.
    Kenna GA; Haass-Koffler CL; Zywiak WH; Edwards SM; Brickley MB; Swift RM; Leggio L
    Addict Biol; 2016 Jul; 21(4):904-14. PubMed ID: 26037245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
    Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
    JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder.
    Brown ES; Van Enkevort E; Kulikova A; Escalante C; Nakamura A; Ivleva EI; Holmes T
    Alcohol Clin Exp Res; 2019 Feb; 43(2):317-323. PubMed ID: 30457668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.
    Rasmussen DD; Beckwith LE; Kincaid CL; Froehlich JC
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1532-9. PubMed ID: 24891220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prazosin for Alcohol Use Disorder: A Symptom-Driven Approach to the Choice of Intervention.
    Andrade C
    J Clin Psychiatry; 2021 Mar; 82(2):. PubMed ID: 34033270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol use disorder severity moderates clinical response to varenicline.
    Donato S; Green R; Ray LA
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1877-1887. PubMed ID: 34486130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
    Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
    Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial.
    Morley KC; Kranzler HR; Luquin N; Jamshidi N; Adams C; Montebello M; Tremonti C; Dali G; Logge W; Baillie A; Teesson M; Trent R; Haber PS
    Am J Psychiatry; 2024 May; 181(5):403-411. PubMed ID: 38706338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of naltrexone in a community treatment program.
    Killeen TK; Brady KT; Gold PB; Simpson KN; Faldowski RA; Tyson C; Anton RF
    Alcohol Clin Exp Res; 2004 Nov; 28(11):1710-7. PubMed ID: 15547458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.